# TestDynamics

> Vendor-neutral imaging-AI evaluation, integration and governance for hospitals and radiology groups.

## Why it is interesting

Hospitals need to test, buy, monitor and replace competing FDA-cleared imaging algorithms; Satori offers one clinical contract and connector rather than one procurement/integration per algorithm. The disclosed $9M covers a financing announcement involving a Series A, not necessarily a fully specified $9M Series A tranche.

## Profile

- **Latest funding:** Series A announced; amount represents issuer's $9M funding disclosure, Series A tranche not separately specified — $9M disclosed funding (tranche split undisclosed) (November 16, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** $9M
- **Stage:** series-a
- **Status:** private
- **Industries:** N/A
- **Coverage:** full
- **Last updated:** 2026-11-18
- **Latest funding investors:** Healthier Capital, Cedars-Sinai Technology Ventures

## Key facts

- Issuer Business Wire release 2026-11-16: $9M funding announced, Series A led by Healthier Capital; Cedars-Sinai Technology Ventures participated. https://www.businesswire.com/news/home/20261116497451/en/
- The original release does not state the new Series A tranche size separately, so $9M is recorded as total announced funding, not a mathematically proven single-round amount.
- Vendor Satori implementation stages and single BAA/PACS workflow: https://testdynamics.net/platform/
- Vendor-selected clinical-use claims must not be interpreted as clinical outcome evidence or FDA clearance for the Satori platform.

## Funding history

- Series A announced; amount represents issuer's $9M funding disclosure, Series A tranche not separately specified · $9M disclosed funding (tranche split undisclosed) · November 16, 2026
  Source: https://www.businesswire.com/news/home/20261116497451/en/

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** November 18, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/testdynamics-satori
